Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 14, 2014; 20(30): 10355-10367
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10355
Table 5 Recommended treatment regimens for Helicobacter pylori eradication in West Asia
First-line therapeutic options:
10-d Bismuth-Furazolidone Quadruple therapy:
Pantoprazole 40 mg BD + Amoxicillin 1 g BD + Bismuth 240 mg BD for 10 d; Metronidazole 500 mg BD just over the first 5 d and Furazolidone 200 mg BD over the second 5 d
14-d Clarithromycin-containing Hybrid therapy:
Pantoprazole 40 mg BD + Amoxicillin 1 g BD for 14 d and Clarithromycin 500 mg BD + Tinidazole 500 mg BD just over the last 7 d
14-d Omeprazole-Bismuth-Tetracycline-Metronidazole, if:
Omeprazole 20 mg BD + Bismuth 240 mg BD + Tetracycline 500 mg QID + Metronidazole 500 mg TDS for 14 d
Second-line therapeutic options:
14-d Omeprazole-Bismuth-Tetracycline-Furazolidone:
Omeprazole 20 mg BD + Bismuth 240 mg BD + Tetracycline 500 mg BD + Furazolidone 200 mg BD (if Furazolidone is not used as first-line)
14-d Ranitidine-Bismuth-Tetracycline-Metronidazole:
Ranitidine-Bismuth 400 mg BD + Tetracycline 500 mg BD + Metroidazole 500 mg BD
7-d Rabeprazole-Amoxicillin-Gatifloxacin:
Rabeprazole 20 mg BD + Amoxicillin 1 g BD + Gatifloxacin 400 mg Daily
14-d Omeprazole-Bismuth-Azithromycin-Ofloxacin:
Omeprazole 20 mg BD + Bismuth 240 mg BD + Azithromycin 250 mg BD + Ofloxacin 200 mg BD
Third-line therapeutic options:
The optimal regimen must be chosen according to the pattern of antibiotic susceptibility of H. pylori1